Autonomyo secures EUR 1.4 million and launches crowdfunding to scale safe home rehabilitation
13.11.2025
Renens-based Medtech startup Autonomyo, founded at EPFL, has raised EUR 1.4 million from private and public investors and launched a crowdfunding campaign on Capital Cell to bring its home rehabilitation technology to a global market. With its Skywalk system, which combines a safety frame, a smart exoskeleton, and a digital therapy platform, Autonomyo aims to make robot-assisted rehabilitation accessible beyond clinical environments.
 Co-Founders Amalric Ortlieb and Fabian Bischof
|
 |
Every year, more than 15 million people suffer a stroke, and nearly half of them leave rehabilitation unable to walk independently — not because recovery is impossible, but because intensive therapy remains too expensive and limited to specialized centers. Autonomyo addresses this gap with Skywalk, the world’s first intelligent safety frame designed for safe, assisted gait training at home. When paired with the company’s wearable exoskeleton and digital rehabilitation platform, the system enables patients to practice walking daily in a controlled and affordable way.
Autonomyo’s technology has already been successfully tested at CHUV (University Hospital of Lausanne), showing promising results for home-based motor recovery. The company is now working toward CE certification and FDA readiness in 2025 to enter European and US markets.
With the new funding and ongoing crowdfunding campaign, Autonomyo—a Venture Kick winner—plans to accelerate the industrialization of its Skywalk and Exoskeleton V3, expand digital training programs, and scale production to reach thousands of households worldwide. By involving the public in its next growth phase, Autonomyo invites supporters to participate in its mission to restore independence to millions of people affected by mobility loss.
Autonomyo’s technology has already been successfully tested at CHUV (University Hospital of Lausanne), showing promising results for home-based motor recovery. The company is now working toward CE certification and FDA readiness in 2025 to enter European and US markets.
With the new funding and ongoing crowdfunding campaign, Autonomyo—a Venture Kick winner—plans to accelerate the industrialization of its Skywalk and Exoskeleton V3, expand digital training programs, and scale production to reach thousands of households worldwide. By involving the public in its next growth phase, Autonomyo invites supporters to participate in its mission to restore independence to millions of people affected by mobility loss.